Business Context and Reporting Period
Company: Wearable Devices Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Date: September 25, 2025
Principal Executive Offices: 5 Ha-Tnufa Street, Yokne-am Illit, Israel 2066736
This filing reports the execution of an "at-the-market" (ATM) Sales Agreement with A.G.P./Alliance Global Partners, allowing the Company to offer and sell ordinary shares up to a specified limit.
Key Financial Metrics
The filing does not provide specific financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on the terms of a new equity financing arrangement.
| Metric | Value |
|---|---|
| Maximum Offering Amount | $7,400,000 |
| Commission Rate | 3.0% of aggregate gross proceeds |
| Use of Proceeds | Working capital and general corporate purposes |
Material Changes
There are no material changes to financial performance reported in this filing. The primary material event is the establishment of a new sales mechanism for equity issuance under the Company's existing Registration Statement on Form F-3 (File No. 333-274841).
Guidance, Outlook, and Risks
- Management Commentary: The Company is not obligated to sell any shares under the agreement. Sales will be conducted at the Company's discretion based on instructions regarding price, time, and size limits.
- Outlook: Proceeds are intended for working capital and general corporate purposes.
- Risks and Contingencies: The Sales Agent's obligations are subject to customary closing conditions. The filing includes standard legal disclaimers stating that the report does not constitute an offer to sell in jurisdictions where such an offer would be unlawful.
Investor Verification Checklist
- Verify the current market price of Wearable Devices Ltd. ordinary shares to assess potential dilution impact from the $7.4 million ATM facility.
- Review the attached Sales Agreement (Exhibit 10.1) for specific price floors or volume limits not detailed in the summary.
- Confirm the status of the underlying Registration Statement on Form F-3 (File No. 333-274841) to ensure it remains effective.
- Monitor future filings for actual share sales executed under this agreement and the resulting cash inflows.